Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Vanda Pharmaceuticals Inc. (VNDA)  
$4.62 0.14 (3.12%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 61,398,000
Market Cap: 283.66(M)
Last Volume: 821,939 Avg Vol: 693,736
52 Week Range: $3.38 - $6.95
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  803
Guru Rank Value     : 1
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 121,098 121,098 148,134 388,157
Total Sell Value $513,345 $513,345 $684,141 $2,735,436
Total People Sold 5 5 6 8
Total Sell Transactions 10 10 14 33
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 549
  Page 2 of 22  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Birznieks Gunther SVP, Business Development   •       –      –    2023-03-03 4 S $6.26 $51,791 D/D (8,268) 205,980 5%     
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2023-03-03 4 S $6.32 $25,994 D/D (4,113) 117,540 5%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2023-03-03 4 S $6.25 $140,876 D/D (22,538) 1,476,902 5%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2023-03-03 4 S $6.28 $37,499 D/D (5,968) 138,926 5%     
   Williams Timothy SVP & General Counsel   •       –      –    2023-03-03 4 S $6.25 $51,887 D/D (8,301) 103,513 5%     
   Birznieks Gunther SVP, Business Development   •       –      –    2023-03-02 4 S $6.20 $52,793 D/D (8,509) 214,248 1%     
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2023-03-02 4 S $6.23 $48,123 D/D (7,720) 121,653 1%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2023-03-02 4 S $6.23 $139,718 D/D (22,426) 1,499,440 1%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2023-03-02 4 S $6.26 $49,846 D/D (7,966) 144,894 1%     
   Williams Timothy SVP & General Counsel   •       –      –    2023-03-02 4 S $6.24 $52,685 D/D (8,437) 111,814 1%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2023-02-16 4 A $0.00 $0 D/D 32,700 152,860     -
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2023-02-16 4 A $0.00 $0 D/D 115,000 1,521,866     -
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2023-02-16 4 A $0.00 $0 D/D 32,700 129,373     -
   Williams Timothy SVP & General Counsel   •       –      –    2023-02-16 4 A $0.00 $0 D/D 32,700 120,251     -
   Birznieks Gunther SVP, Business Development   •       –      –    2023-02-16 4 A $0.00 $0 D/D 32,700 222,757     -
   Williams Timothy SVP & General Counsel   •       –      –    2022-12-15 4 S $7.01 $56,070 D/D (8,000) 87,551 11%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2022-12-06 4 S $10.61 $512,082 D/D (48,250) 1,406,866 42%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2022-12-06 4 OE $3.12 $235,139 D/D 75,365 1,455,116     -
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2022-12-06 4 S $10.61 $50,827 D/D (4,792) 120,160 42%     
   Moran Kevin Patrick SVP, CFO & Treasurer   •       –      –    2022-12-06 4 OE $3.12 $23,400 D/D 7,500 124,952     -
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2022-12-05 4 S $10.62 $506,200 D/D (47,650) 1,379,751 38%     
   Polymeropoulos Mihael Hristos President and CEOChairman of t   •       •      –    2022-12-05 4 OE $3.12 $232,861 D/D 74,635 1,427,401     -
   Birznieks Gunther SVP, Business Development   •       –      –    2022-08-26 4 OE $3.12 $3,900 D/D 1,250 190,057     -
   Wijkstrom Joakim SVP, Chief Marketing Officer   •       –      –    2022-08-22 4 S $10.27 $37,007 D/D (3,605) 96,673 28%     
   Williams Timothy SVP & General Counsel   •       –      –    2022-08-15 4 S $10.21 $85,504 D/D (8,300) 95,551 34%     

  549 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 2 of 22
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed